CRISPR Therapeutics (NASDAQ:CRSP) is one of the most exciting biotechs on the market today, because it’s pushing the limits of what is possible when it comes to treating hereditary diseases. It’s all made possible by the company’s gene-editing technology,…

Click here to view the original article.